STOCK TITAN

Houlihan Lokey, Inc. (HLI) Financials

HLI
Trailing 12 months to June 30, 2026
Revenue $2.5B +1.7% YoY
Net Income $404.0M -1.2% YoY
EPS (Diluted) $5.96 +0.2% YoY
Free Cash Flow $484.8M -34.4% YoY
Market Cap $9.1B as of Oct 10, 2026
Price / Sales 3.6x on $2.5B revenue, trailing 12 months to June 30, 2026
Price / Earnings 22.5x on $404.0M net income, trailing 12 months to June 30, 2026
Price / Book 4.0x on $2.3B equity, Q1 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jun 30, 2026 Reported Currency USD FYE March

Newest figures come from the 10-Q for Q1 FY2027, filed Jul 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HLI SEC filings page.

Houlihan Lokey, Inc. (HLI) reported $2.5B in revenue over the twelve months to Jun 30, 2026, up 1.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HLI FY2026

The business converts reported revenue into substantial cash, while operating margins and leverage remain broadly disciplined through FY2026.

The FY2023 trough was not a lasting cash-economics reset: operating cash flow rose from $136M to $704M by FY2026. That recovery also produced $682M of free cash flow against only $22M of capital spending, showing reported cash generation was not being consumed by heavy reinvestment.

Revenue reached $2.6B in FY2026, while operating margin was 20.1% after reaching a higher level in FY2025. Growth did not fully flow through to operating profit, pointing to cost growth or mix effects rather than simple fixed-cost absorption.

Total assets expanded to $4.3B while debt-to-equity remained below 0.8x, indicating a relatively stable leverage posture as the balance sheet grew. Financing cash flow was -$493M, including $349M of dividends and buybacks, so capital allocation materially reduced internally generated cash.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Earnings Growth Capital Efficiency CreditQuality Stability 54 / 100
Financial Health Score 54/100
Scored as: Banks peer group

Scored against banks for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Houlihan Lokey, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings
99

Houlihan Lokey, Inc. earned a return on assets of 9.8% in fiscal year 2026, which is the profit it made on every dollar of assets on its books. This is down from 10.5% the prior year. Earnings ranks banks on that return over three years, and Houlihan Lokey, Inc. scores 99/100 among other banks.

Growth
75

Houlihan Lokey, Inc. reported revenue of $2.6B in fiscal year 2026, against $2.4B in fiscal year 2025. Growth ranks banks on the three-year path of their net revenue, which is interest income and fee income less the interest they pay out, and Houlihan Lokey, Inc. scores 75/100 among other banks.

Capital
94

Houlihan Lokey, Inc. funded 54.4% of its assets with shareholders' equity at the end of fiscal year 2026, holding $2.3B of equity against $4.3B of assets. Capital ranks banks on that cushion, and Houlihan Lokey, Inc. scores 94/100 among other banks.

Efficiency
0

Not available for Houlihan Lokey, Inc., and counted as zero in the overall score.

Credit Quality
0

Not available for Houlihan Lokey, Inc., and counted as zero in the overall score.

Stability
56

Houlihan Lokey, Inc. reported net income of $424.0M in fiscal year 2026, against $400.0M in fiscal year 2025. Stability ranks banks on how steady net income has been across five years, and Houlihan Lokey, Inc. scores 56/100 among other banks.

Piotroski F-Score Partial
3/5

Houlihan Lokey, Inc. passes 3 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 3 of 4 profitability signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.66x

For every $1 of reported earnings, Houlihan Lokey, Inc. generates $1.66 in operating cash flow ($704.1M OCF vs $424.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$511.0M
YoY-15.5%
QoQ-19.7%
5Y CAGR+6.5%
10Y CAGR+8.9%

Houlihan Lokey, Inc. generated $511.0M in revenue in Q1 2027. This represents a decrease of 15.5% from the same quarter a year earlier. Against the prior quarter it is down 19.7%.

EBITDA
$86.0M
YoY-18.9%
QoQ-35.3%
5Y CAGR-5.1%
10Y CAGR+5.8%

Houlihan Lokey, Inc.'s EBITDA was $86.0M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 18.9% from the same quarter a year earlier. Against the prior quarter it is down 35.3%.

Net Income
$78.0M
YoY-20.4%
QoQ-20.1%
5Y CAGR-1.9%
10Y CAGR+7.1%

Houlihan Lokey, Inc. reported $78.0M in net income in Q1 2027. This represents a decrease of 20.4% from the same quarter a year earlier. Against the prior quarter it is down 20.1%.

EPS (Diluted)
$1.15
YoY-19.0%
QoQ-22.3%
5Y CAGR-1.7%
10Y CAGR+6.9%

Houlihan Lokey, Inc. earned $1.15 per diluted share (EPS) in Q1 2027. This represents a decrease of 19.0% from the same quarter a year earlier. Against the prior quarter it is down 22.3%.

Cash & Balance Sheet

Free Cash Flow
-$342.0M
YoY-135.9%
QoQ-219.3%

Houlihan Lokey, Inc. recorded an outflow of $342.0M in free cash flow in Q1 2027, representing a cash shortfall after capex. This represents a decrease of 135.9% from the same quarter a year earlier. Against the prior quarter it is down 219.3%.

Cash & Debt
$745.0M
YoY-6.2%
QoQ-37.3%
5Y CAGR-1.0%
10Y CAGR+21.5%

Houlihan Lokey, Inc. held $745.0M in cash as of Q1 2027; long-term debt is not reported for that period.

Dividends Per Share
$0.70

Houlihan Lokey, Inc. paid $0.70 per share in dividends in Q1 2027.

Shares Outstanding
Diluted avg 68M

Houlihan Lokey, Inc. had a weighted average of 68M diluted shares in Q1 2027; the shares outstanding count is not reported for that period.

Margins & Returns

Gross Margin
30.1%
YoY-0.9pp

Houlihan Lokey, Inc.'s gross margin was 30.1% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is down 0.9 percentage points from the same quarter a year earlier.

Operating Margin
15.3%
YoY+0.4pp
QoQ-4.4pp
5Y change-13.6pp
10Y change-6.3pp

Houlihan Lokey, Inc.'s operating margin was 15.3% in Q1 2027, reflecting core business profitability. This is up 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.4 percentage points.

Net Margin
15.3%
YoY-0.9pp
QoQ-0.1pp
5Y change-7.8pp
10Y change-2.8pp

Houlihan Lokey, Inc.'s net profit margin was 15.3% in Q1 2027, showing the share of revenue converted to profit. This is down 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.

Return on Equity
3.5%
YoY-1.0pp
QoQ-0.7pp
5Y change-2.8pp
10Y change-2.3pp

Houlihan Lokey, Inc.'s ROE was 3.5% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is down 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.7 percentage points.

Capital Allocation

Share Buybacks
$50.0M
YoY+525.0%
QoQ0.0%
5Y CAGR-5.8%

Houlihan Lokey, Inc. spent $50.0M on share buybacks in Q1 2027, returning capital to shareholders by reducing shares outstanding. This represents an increase of 525.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

Capital Expenditures
$6.0M
YoY-53.8%
QoQ-4.0%
5Y CAGR+33.7%
10Y CAGR-2.1%

Houlihan Lokey, Inc. invested $6.0M in capex in Q1 2027, funding long-term assets and infrastructure. This represents a decrease of 53.8% from the same quarter a year earlier. Against the prior quarter it is down 4.0%.

R&D Spending

Not reported for Q1 2027.

HLI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HLI quarterly income statement
MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-Q
Revenue$511.0M-15.5%$636.0M-4.6%$717.1M+13.0%$659.5M+14.7%$605.0M+17.8%$666.4M+28.0%$634.4M+24.1%$575.0M+23.1%
Gross Profit$154.0M-18.1%N/A$230.7M+15.9%$222.8M+17.3%$188.0M+19.6%$226.0M+43.5%$199.1M+32.0%$190.0M+33.2%
SG&A Expenses$314.0M-15.6%$391.2M-4.5%$441.0M+13.0%$405.6M+14.7%$372.0M+17.8%$409.9M+31.2%$390.2M+24.1%$353.6M+23.1%
Operating Income$78.0M-13.3%$124.9M-11.4%$160.7M+18.1%$151.3M+15.8%$90.0M-5.0%$141.1M+24.8%$136.1M+41.0%$130.7M+44.7%
EBITDA$86.0M-18.9%$133.0M-15.0%$169.0M+16.0%$161.6M+17.0%$106.0M+2.3%$156.5M+29.0%$145.7M+41.2%$138.1M+41.9%
Income Tax$8.0M$36.7M+29.6%$53.1M+6.6%$48.3M+13.5%$0-100.0%$28.3M-23.3%$49.8M+56.8%$42.5M+60.3%
Net Income$78.0M-20.4%$97.7M-20.1%$116.5M+22.3%$111.8M+19.5%$98.0M+10.2%$122.2M+51.3%$95.3M+34.6%$93.5M+39.6%
EPS (Basic)$1.17-20.4%$1.51-17.9%$1.75+20.7%$1.67+17.6%$1.47+7.3%$1.84+46.0%$1.45+31.8%$1.42+36.5%
EPS (Diluted)$1.15-19.0%$1.48-16.4%$1.70+22.3%$1.63+19.0%$1.42+9.2%$1.77+50.0%$1.39+33.7%$1.37+38.4%
Diluted Shares (Avg)68M-1.9%N/A68M-0.5%69M+0.2%69M+0.6%N/A69M+1.3%68M+0.8%

Not reported in any period shown, so not listed: Cost of Revenue, R&D Expenses, Interest Expense.

HLI Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HLI quarterly balance sheet
MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-Q
Total Assets$3.7B+5.7%$4.3B+12.8%$3.9B+13.3%$3.8B+18.1%$3.5B+19.5%$3.8B+20.5%$3.5B+17.5%$3.2B+15.5%
Cash & Equivalents$745.0M-6.2%$1.2B+22.5%$1.1B+32.2%$923.6M+33.6%$793.8M+76.5%$971.0M+34.6%$799.3M+43.9%$691.4M+40.0%
Short-Term Investments$0$0$0$0$0$0$0$0
Accounts Receivable$224.0M+2.7%$228.0M-11.4%$210.9M+26.5%$251.2M+14.6%$218.2M+13.3%$257.3M+28.9%$166.7M+9.1%$219.1M+43.9%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$1.4B+7.8%$1.4B+8.7%$1.3B+1.0%$1.3B+9.7%$1.3B+10.2%$1.3B+13.9%$1.3B+13.4%$1.2B+8.4%
Total Liabilities$1.4B+0.9%$1.9B+12.8%$1.6B+17.8%$1.5B+23.2%$1.3B+20.3%$1.6B+23.3%$1.4B+17.3%$1.3B+10.6%
Total Equity$2.3B+3.5%$2.3B+7.7%$2.3B+10.2%$2.2B+14.8%$2.2B+19.1%$2.2B+18.4%$2.1B+17.6%$2.0B+18.9%
Retained Earnings$1.7B+15.0%$1.6B+17.9%$1.6B+20.8%$1.5B+20.3%$1.4B+20.0%$1.4B+19.9%$1.3B+17.3%$1.3B+15.9%

Not reported in any period shown, so not listed: Current Assets, Inventory, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

HLI Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HLI quarterly cash flow statement
MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-Q
Operating Cash Flow-$336.0M-154.5%$293.0M-18.2%$217.7M-18.0%$325.4M+12.5%-$132.0M-104.6%$358.4M+59.1%$265.5M+163.2%$289.2M+112.9%
Depreciation & Amortization$8.0M-50.0%$8.0M-47.8%$8.3M-13.2%$10.3M+38.4%$16.0M+80.7%$15.4M+86.5%$9.6M+43.6%$7.4M+5.1%
Stock-Based Compensation$45.0M+7.1%N/A$60.9M+33.6%$46.6M+2.9%$42.0M+27.0%N/A$45.6M+3.7%$45.3M+6.0%
Capital Expenditures$6.0M-53.8%$6.3M-56.8%$639K-83.4%$2.4M-76.9%$13.0M+19.6%$14.5M+18.5%$3.9M-75.3%$10.5M-54.9%
Free Cash Flow-$342.0M-135.9%$286.8M-16.6%$217.0M-17.1%$323.0M+15.9%-$145.0M-92.4%$343.9M+61.4%$261.7M+206.7%$278.7M+147.7%
Investing Cash Flow$112.0M+1.8%-$49.6M+53.4%$56.4M+164.5%-$114.6M-271.2%$110.0M+372.1%-$106.3M-624.1%-$87.4M-284.3%-$30.9M-49.8%
Financing Cash Flow-$217.0M-10.2%-$92.8M-1.9%-$131.4M-251.7%-$71.8M-83.4%-$197.0M-22.0%-$91.1M-152.0%-$37.4M-4.9%-$39.1M+42.2%
Dividends Paid$61.0M+15.1%$39.2M+1.7%$40.6M+9.7%$41.3M+7.4%$53.0M+3.4%$38.5M+8.3%$37.0M+4.3%$38.4M+8.4%
Share Buybacks$50.0M+525.0%$50.0M-4.2%$87.9M+102105.8%$29.5M$8.0M+3233.3%$52.2M$86K$0-100.0%

HLI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HLI quarterly financial ratios
MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-Q
Gross Margin30.1%-0.9ppN/A32.2%+0.8pp33.8%+0.7pp31.1%+0.5pp33.9%+3.7pp31.4%+1.9pp33.0%+2.5pp
Operating Margin15.3%+0.4pp19.7%-1.5pp22.4%+1.0pp22.9%+0.2pp14.9%-3.6pp21.2%-0.6pp21.4%+2.6pp22.7%+3.4pp
Net Margin15.3%-0.9pp15.4%-3.0pp16.3%+1.2pp17.0%+0.7pp16.2%-1.1pp18.3%+2.8pp15.0%+1.2pp16.3%+1.9pp
Return on Equity3.5%-1.0pp4.2%-1.4pp5.1%+0.5pp5.0%+0.2pp4.5%-0.4pp5.6%+1.2pp4.6%+0.6pp4.8%+0.7pp
Return on Assets2.1%-0.7pp2.3%-0.9pp3.0%+0.2pp2.9%0.0pp2.8%-0.2pp3.2%+0.7pp2.7%+0.3pp2.9%+0.5pp
Debt-to-Equity0.600.0x0.790.0x0.720.0x0.690.0x0.620.0x0.760.0x0.670.0x0.640.0x
Asset Turnover0.140.0x0.150.0x0.180.0x0.170.0x0.170.0x0.170.0x0.180.0x0.180.0x
FCF Margin-66.9%-43.0pp45.1%-6.5pp30.3%-11.0pp49.0%+0.5pp-24.0%-9.3pp51.6%+10.7pp41.2%+24.6pp48.5%+24.4pp

Not reported in any period shown, so not listed: Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Houlihan Lokey, Inc. HLI FY2026 $2.6B $424.0M 16.2% $9.1B 54/100
Evercore Inc. EVR FY2025 $3.9B $592.0M 15.3% $10.5B 52/100
Jefferies Financial Group Inc. JEF FY2025 $7.3B $682.0M 9.3% $10.2B 41/100
Stifel Financial Corp. SF FY2025 $5.5B $646.5M 11.7% $10.6B 53/100
Tradeweb Markets Inc. TW FY2025 $2.1B $812.8M 39.6% $23.4B 52/100
LPL Financial Holdings Inc. LPLA FY2025 $17.0B $863.0M 5.1% $26.1B 54/100

Frequently Asked Questions

What is Houlihan Lokey, Inc.'s annual revenue?

Houlihan Lokey, Inc. (HLI) reported $2.6B in total revenue for fiscal year 2026. This represents a 9.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Houlihan Lokey, Inc.'s revenue growing?

Houlihan Lokey, Inc. (HLI) revenue grew by 9.5% year-over-year, from $2.4B to $2.6B in fiscal year 2026.

Is Houlihan Lokey, Inc. profitable?

Yes, Houlihan Lokey, Inc. (HLI) reported a net income of $424.0M in fiscal year 2026, with a net profit margin of 16.2%.

Houlihan Lokey, Inc. (HLI) reported diluted earnings per share of $6.22 for fiscal year 2026. This represents a 6.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Houlihan Lokey, Inc. (HLI) had EBITDA of $569.7M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

Houlihan Lokey, Inc. (HLI) had an operating margin of 20.1% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

Houlihan Lokey, Inc. (HLI) had a net profit margin of 16.2% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Houlihan Lokey, Inc. (HLI) has a return on equity of 18.1% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

Houlihan Lokey, Inc. (HLI) generated $681.8M in free cash flow during fiscal year 2026. This represents a -15.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Houlihan Lokey, Inc. (HLI) generated $704.1M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

Houlihan Lokey, Inc. (HLI) had $4.3B in total assets as of fiscal year 2026, including both current and long-term assets.

Houlihan Lokey, Inc. (HLI) invested $22.3M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Yes, Houlihan Lokey, Inc. (HLI) spent $175.4M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

Houlihan Lokey, Inc. (HLI) had a debt-to-equity ratio of 0.79 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

Houlihan Lokey, Inc. (HLI) had a return on assets of 9.8% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Houlihan Lokey, Inc. (HLI) trades at 22.5x earnings, its market capitalization divided by net income of $404.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $9.1B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Houlihan Lokey, Inc. (HLI) trades at 3.6x sales, its market capitalization divided by revenue of $2.5B revenue, trailing 12 months to June 30, 2026. The market capitalization is $9.1B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Houlihan Lokey, Inc. (HLI) has a Piotroski F-Score of 3 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Houlihan Lokey, Inc. (HLI) has an earnings quality ratio of 1.66x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Houlihan Lokey, Inc. (HLI) scores 54 out of 100 on our Financial Health Score, indicating moderate standing within its banks peer group. The score is a 0-100 composite of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top